Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke
Public ClinicalTrials.gov record NCT02930018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ESCAPE-NA-1 study is designed to determine the safety and efficacy of the neuroprotectant, Nerinetide (NA-1), in reducing global disability in subjects with major acute ischemic stroke (AIS) with a small established infarct core and with good collateral circulation who are selected for endovascular revascularization.
Study identification
- NCT ID
- NCT02930018
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,105 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2017
- Primary completion
- Nov 19, 2019
- Completion
- Nov 19, 2019
- Last update posted
- Oct 9, 2022
2017 – 2019
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 90095 | — |
| California Pacific Medical Center - Davies Campus | San Francisco | California | 94114 | — |
| Providence Little Company of Mary Medical Center Torrance | Torrance | California | 90503 | — |
| Swedish Medical Center | Englewood | Colorado | 80110 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | — |
| Baptist Health Medical Center | Jacksonville | Florida | 32207 | — |
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | — |
| WellStar Health Systems | Marietta | Georgia | 30060 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | — |
| Saint Luke's Hospital of Kansas City | Kansas City | Missouri | 64111 | — |
| NYU Lutheran Medical Center | Brooklyn | New York | 11220 | — |
| Novant Health Forsyth Medical Center | Winston-Salem | North Carolina | 27103 | — |
| Riverside Radiology | Columbus | Ohio | 43214 | — |
| Abington Memorial Hospital | Philadelphia | Pennsylvania | 19001 | — |
| UPMC Presbyterian | Pittsburgh | Pennsylvania | 15213 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Chattanooga Center for Neurologic Research | Chattanooga | Tennessee | 37403 | — |
| Valley Baptist Medical Center | Harlingen | Texas | 78550 | — |
| Swedish Medical Center- Cherry Hill Campus | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02930018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02930018 live on ClinicalTrials.gov.